BioSpace News Archive

Jaguar Health today announced that the European Commission has adopted the decision to grant Orphan Drug Designation (ODD) for crofelemer for the indication of microvillus inclusion disease (MVID), a rare congenital diarrheal disorder (CDD) condition.

Cambridge Isotope Laboratories, Inc., the world leader in stable isotope chemistry and the separation of carbon-13, has embarked on the largest expansion in the company’s history.

Oculis, SA. (“Oculis”), a global biopharmaceutical company developing treatments to save sight and improve eye care with breakthrough innovations and European Biotech Acquisition Corp (“EBAC”, NASDAQ: EBAC), a special purpose acquisition company (SPAC), today announced they have entered into a definitive business combination agreement.

INVO Bioscience, Inc. (NASDAQ: INVO) today announced the company will exhibit at the 2022 Scientific Congress & Expo of the American Society for Reproductive Medicine (ASRM).

Plexision, a biotechnology company, is offering the first blood test panel capable of reporting the risk of cytomegalovirus infection and transplant rejection within six hours after samples arrive at its reference laboratory.

Gestalt Diagnostics, Inc., will be debuting the newest version of PathFlow, our award-winning, pathologist-proven digital pathology solution during the Digital Pathology Association’s Pathology Visions 22 Conference in Las Vegas, October 16-18, 2022.

CorePlus Servicios Clínicos y Patológicos, LLC (CorePlus), a leader in AI-based solutions for cancer detection in pathology, is scaling their expertise in digital pathology to new heights in 3D with Alpenglow Biosciences’ full 3D spatial biology offering.

According to Nova one advisor, the global Neurology Clinical Trials market was valued at USD 6.1 billion in 2021 and it is expected to hit around USD 10.7 billion by 2030 with a CAGR of 5.9% during the forecast period 2022 to 2030.

SHINE Technologies, a next-generation fusion technology company, and SHINE Europe announced today that the Dutch government has approved a substantial grant proposal to develop a plan to produce a variety of terbium isotopes for use in nuclear medicine.

Data scientist and statistician Katie Pollard, PhD, director of the Gladstone Institute of Data Science and Biotechnology, has been elected to the National Academy of Medicine, one of the highest honors in health and medicine.